We develop improved diagnostic testing for conditions related to metabolic dysfunction, including chronic kidney, liver and cardiac diseases.
From a single serum sample, we quantify multiple biomarkers — known and newly discovered. Precision Diagnostics.
Using FDA-cleared technology, this is our core platform. It incorporates diagnostic testing algorithms into nuclear magnetic resonance (NMR) spectroscopy. It's the first modular software-based system for clinical diagnostics.
News
2
Locations: Houston, Texas;
Regensburg, Germany
2004
Founded as a spin-off of
Regensburg University, Regensburg, Germany
3.5 M
Tests performed globally
Press Releases